SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jessica E. Morgan, Karl McKeever, Kay S. Tyerman, Michael Henderson, Susan Picton, Robert S. Phillips, Aminoaciduria in the prediction of ifosfamide-induced tubulopathy after childhood cancer: a feasibility study, Pilot and Feasibility Studies, 2016, 2, 1

    CrossRef

  2. 2
    George Liamis, Theodosios D. Filippatos, Moses S. Elisaf, Electrolyte disorders associated with the use of anticancer drugs, European Journal of Pharmacology, 2016, 777, 78

    CrossRef

  3. 3
    Leonilde Bonfrate, Giuseppe Procino, David Q.-H. Wang, Maria Svelto, Piero Portincasa, A novel therapeutic effect of statins on nephrogenic diabetes insipidus, Journal of Cellular and Molecular Medicine, 2015, 19, 2
  4. 4
    Hélène Sudour-Bonnange, Audrey Vanrenterghem, François Nobili, Vincent Guigonis, Bernard Boudailliez, Complications rénales à long terme chez les patients traités pour un cancer dans l’enfance, Bulletin du Cancer, 2015, 102, 7-8, 627

    CrossRef

  5. You have free access to this content5
    Lauren N. Faught, Michael J. E. Greff, Michael J. Rieder, Gideon Koren, Drug-induced acute kidney injury in children, British Journal of Clinical Pharmacology, 2015, 80, 4
  6. 6
    Mustafa Arga, Aynur Oguz, Faruk Guclu Pinarli, Ceyda Karadeniz, Elvan Caglar Citak, Hamdi Cihan Emeksiz, Esra Akdeniz Duran, Oguz Soylemezoglu, Risk factors for cisplatin-induced long-term nephrotoxicity in pediatric cancer survivors, Pediatrics International, 2015, 57, 3
  7. 7
    Gregory J. Latham, Anesthesia for the Child with Cancer, Anesthesiology Clinics, 2014, 32, 1, 185

    CrossRef

  8. 8
    Arul P. Lionel, Girish Chinnaswamy, Rikki R. John, Sarah Mathai, Ifosfamide Induced Renal Rickets, The Indian Journal of Pediatrics, 2014, 81, 9, 943

    CrossRef

  9. 9
    Katja Berger, Marcus J. Moeller, Mechanisms of Epithelial Repair and Regeneration After Acute Kidney Injury, Seminars in Nephrology, 2014, 34, 4, 394

    CrossRef

  10. 10
    Małgorzata Zubowska, Krystyna Wyka, Wojciech Fendler, Wojciech Młynarski, Beata Zalewska-Szewczyk, Interleukin 18 as a Marker of Chronic Nephropathy in Children after Anticancer Treatment, Disease Markers, 2013, 35, 811

    CrossRef

  11. 11
    Sunil Kumar Sahai, Perioperative assessment of the cancer patient, Best Practice & Research Clinical Anaesthesiology, 2013, 27, 4, 465

    CrossRef

  12. 12
    Roderick Skinner, Rana Kaplan, Paul C. Nathan, Renal and Pulmonary Late Effects of Cancer Therapy, Seminars in Oncology, 2013, 40, 6, 757

    CrossRef

  13. 13
    Michelle Greene, Magdalena Kobierska, Paul M. Kent, Patricia Piasecki, Survivorship in young patients with bone cancer, Current Problems in Cancer, 2013, 37, 4, 236

    CrossRef

  14. 14
    P. Abou Jaoude, L. Dubourg, J. Bacchetta, J. Berthiller, B. Ranchin, P. Cochat, Congenital versus acquired solitary kidney: is the difference relevant?, Nephrology Dialysis Transplantation, 2011, 26, 7, 2188

    CrossRef

  15. 15
    Nancy Chen, Lauren Hanly, Michael Rieder, Herman Yeger, Gideon Koren, The effect ofN-acetylcysteine on the antitumor activity of ifosfamide, Canadian Journal of Physiology and Pharmacology, 2011, 89, 5, 335

    CrossRef

  16. 16
    GREGORY J. LATHAM, ROBERT S. GREENBERG, Anesthetic considerations for the pediatric oncology patient – part 2: systems-based approach to anesthesia, Pediatric Anesthesia, 2010, 20, 5
  17. 17
    GREGORY J. LATHAM, ROBERT S. GREENBERG, Anesthetic considerations for the pediatric oncology patient – Part 3: pain, cognitive dysfunction, and preoperative evaluation, Pediatric Anesthesia, 2010, 20, 6
  18. 18
    Patrina Gunness, Katarina Aleksa, Kazuhiro Kosuge, Shinya Ito, Gideon Koren, Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity, Canadian Journal of Physiology and Pharmacology, 2010, 88, 4, 448

    CrossRef

  19. 19
    Norbert Lameire, Wim Van Biesen, Raymond Vanholder, Electrolyte Disturbances and Acute Kidney Injury in Patients With Cancer, Seminars in Nephrology, 2010, 30, 6, 534

    CrossRef

  20. 20
    Roderick Skinner, Annie Parry, Lisa Price, Michael Cole, Alan W. Craft, Andrew D.J. Pearson, Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose, Pediatric Blood & Cancer, 2010, 54, 7
  21. 21
    Roderick Skinner, Nephrotoxicity of cancer treatment in children, Pediatric Health, 2010, 4, 5, 519

    CrossRef

  22. 22
    Bérénice Giraud, Guillaume Hebert, Alain Deroussent, Gareth J Veal, Gilles Vassal, Angelo Paci, Oxazaphosphorines: new therapeutic strategies for an old class of drugs, Expert Opinion on Drug Metabolism & Toxicology, 2010, 6, 8, 919

    CrossRef

  23. 23
    Amir Sonnenblick, Amichay Meirovitz, Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature, International Journal of Clinical Oncology, 2010, 15, 4, 420

    CrossRef

  24. 24
    Katherine A Janeway, Holcombe E Grier, Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects, The Lancet Oncology, 2010, 11, 7, 670

    CrossRef

  25. 25
    Vaibhav Sahni, Devasmita Choudhury, Ziauddin Ahmed, Chemotherapy-associated renal dysfunction, Nature Reviews Nephrology, 2009, 5, 8, 450

    CrossRef

  26. 26
    Margarett Shnorhavorian, Debra L. Friedman, Martin A. Koyle, Genitourinary long-term outcomes for childhood cancer survivors, Current Urology Reports, 2009, 10, 2, 134

    CrossRef

  27. 27
    Lauren Hanly, Nancy Chen, Michael Rieder, Gideon Koren, Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention, Expert Opinion on Drug Safety, 2009, 8, 2, 155

    CrossRef

  28. 28
    Lisa B. Kenney, Lisa Diller, Oncology of Infancy and Childhood, 2009,

    CrossRef

  29. 29
    Orson W. Moe, Donald W. Seldin, Michel Baum, Genetic Diseases of the Kidney, 2009,

    CrossRef

  30. You have free access to this content30
    Carola A.S. Arndt, Douglas S. Hawkins, William H. Meyer, Susan F. Sencer, Joseph P. Neglia, James R. Anderson, Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the Children's Oncology Group, Pediatric Blood & Cancer, 2008, 50, 1
  31. 31
    Cristina Meazza, Gianni Bisogno, Michela Casanova, Ilaria Zanetti, Modesto Carli, Andrea Ferrari, Full-dose ifosfamide can be safely administered to outpatients, Pediatric Blood & Cancer, 2008, 50, 2
  32. 32
    Marika H. Grönroos, Timo Jahnukainen, Merja Möttönen, Mikko Perkkiö, Kerttu Irjala, Toivo T. Salmi, Long-term follow-up of renal function after high-dose methotrexate treatment in children, Pediatric Blood & Cancer, 2008, 51, 4
  33. 33
    N Chen, K Aleksa, C Woodland, M Rieder, G Koren, N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats, British Journal of Pharmacology, 2008, 153, 7
  34. 34
    Pete Anderson, David Kornguth, Kamran Ahrar, Dennis Hughes, Phil Phan, Winston Huh, Kathleen Cornelius, Anita Mahajan, Recurrent, refractory, metastatic and/or unresectable pediatric sarcomas: treatment options for young people ‘off the roadmap’, Pediatric Health, 2008, 2, 5, 605

    CrossRef

  35. 35
    Deborah P. Jones, Sheri L. Spunt, Daniel Green, James E. Springate, Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology Group, Pediatric Blood & Cancer, 2008, 51, 6
  36. 36
    Emily S. Tonorezos, Kevin C. Oeffinger, Survivorship After Childhood, Adolescent, and Young Adult Cancer, The Cancer Journal, 2008, 14, 6, 388

    CrossRef

  37. 37
    Malcolm Lawson, Arthur Vasilaras, Annamarie De Vries, Peter MacTaggart, David Nicol, Urological implications of cyclophosphamide and ifosfamide, Scandinavian Journal of Urology and Nephrology, 2008, 42, 4, 309

    CrossRef

  38. 38
    John M. Pettifor, What’s new in hypophosphataemic rickets?, European Journal of Pediatrics, 2008, 167, 5, 493

    CrossRef

  39. 39
    D. Appenroth, T. Werner, A. Lupp, L. Patzer, J. Misselwitz, C. Fleck, Efforts to establish an animal model of Fanconi syndrome after ifosfamide administration to rats, Journal of Applied Toxicology, 2007, 27, 4
  40. 40
    J.S. Schlondorff, G.P. Mendez, H.G. Rennke, C.C. Magee, Electrolyte abnormalities and progressive renal failure in a cancer patient, Kidney International, 2007, 71, 11, 1181

    CrossRef

  41. 41
    Wolfgang Stöhr, Ludwig Patzer, Marios Paulides, Anja Kremers, Jörn-Dirk Beck, Thorsten Langer, Rainer Rossi, Growth impairment after ifosfamide-induced nephrotoxicity in children, Pediatric Blood & Cancer, 2007, 48, 5
  42. 42
    W. Stöhr, M. Paulides, S. Bielack, H. Jürgens, J. Treuner, R. Rossi, T. Langer, J.D. Beck, Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: A report from the Late Effects Surveillance System, Pediatric Blood & Cancer, 2007, 48, 4
  43. 43
    Herwig Lackner, Andrea Moser, Petra Sovinz, Martin Benesch, Wolfgang Schwinger, Christian Urban, Langzeitbetreuung junger Erwachsener nach Krebserkrankung im Kindesalter – Wohin führt der Weg?, Wiener klinische Wochenschrift, 2007, 119, 11-12, 361

    CrossRef

  44. 44
    George Pentheroudakis, Nicholas Pavlidis, Late toxicity in survivors from adolescent cancers, Cancer Treatment Reviews, 2007, 33, 7, 656

    CrossRef

  45. 45
    D. N. Church, A. B. Hassan, S. J. Harper, C. J. Wakeley, C. G. A. Price, Osteomalacia as a Late Metabolic Complication of Ifosfamide Chemotherapy in Young Adults: Illustrative Cases and Review of the Literature, Sarcoma, 2007, 2007, 1

    CrossRef

  46. 46
    Shuichi Okada, Teruaki Hongo, Kimiyoshi Sakaguchi, Kazunori Suzuki, Shigeru Nishizawa, Takehiko Ohzeki, Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma, Child's Nervous System, 2007, 23, 4, 407

    CrossRef

  47. 47
    Susan B. Nunez, Daniel A. Mulrooney, Caroline Laverdiere, Melissa M. Hudson, Risk-based health monitoring of childhood cancer survivors: A report from the children’s oncology group, Current Oncology Reports, 2007, 9, 6, 440

    CrossRef

  48. 48
    A.-G. Chaume, C. Berger, P. Cathébras, Séquelles et qualité de vie chez de jeunes adultes survivants de cancers pédiatriques, La Revue de Médecine Interne, 2007, 28, 7, 450

    CrossRef

  49. 49
    Nancy Chen, Katarina Aleksa, Cindy Woodland, Michael Rieder, Gideon Koren, The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells, Translational Research, 2007, 150, 1, 51

    CrossRef

  50. 50
    Andreas Benesic, Gerald Schwerdt, Ruth Freudinger, Sigrid Mildenberger, Franziska Groezinger, Brigitte Wollny, Antje Kirchhoff, Michael Gekle, Chloroacetaldehyde as a Sulfhydryl Reagent: The Role of Critical Thiol Groups in Ifosfamide Nephropathy, Kidney and Blood Pressure Research, 2006, 29, 5, 280

    CrossRef

  51. 51
    Gerald Schwerdt, Nader Gordjani, Andreas Benesic, Ruth Freudinger, Brigitte Wollny, Antje Kirchhoff, Michael Gekle, Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells, Pediatric Nephrology, 2006, 21, 1, 60

    CrossRef

  52. 52
    Peter Anderson, Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide-containing chemotherapy in osteosarcoma, Future Oncology, 2006, 2, 3, 333

    CrossRef

  53. 53
    Maja J.A. de Jonge, Jaap Verweij, Renal Toxicities of Chemotherapy, Seminars in Oncology, 2006, 33, 1, 68

    CrossRef

  54. 54
    Robert E Goldsby, Denah R Taggart, Arthur R Ablin, Surviving Childhood Cancer, Pediatric Drugs, 2006, 8, 2, 71

    CrossRef

  55. 55
    Andreas Benesic, Gerald Schwerdt, Sigrid Mildenberger, Ruth Freudinger, Nader Gordjani, Michael Gekle, Disturbed Ca2+-signaling by chloroacetaldehyde: A possible cause for chronic ifosfamide nephrotoxicity, Kidney International, 2005, 68, 5, 2029

    CrossRef

  56. 56
    Jill P. Ginsberg, Richard B. Womer, Preventing organ-specific chemotherapy toxicity, European Journal of Cancer, 2005, 41, 17, 2690

    CrossRef

  57. 57
    Stefano Ferrari, Franca Pieretti, Elisabetta Verri, Loredana Tolentinis, Marilena Cesari, Michela Versari, Carola Zolezzi, Gaetano Lamanna, Gaetano Bacci, Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cisplatin and high-dose methotrexate, Anti-Cancer Drugs, 2005, 16, 7, 733

    CrossRef

  58. 58
    El??bieta Zieli??ska, Ma??gorzata Zubowska, Konrad Misiura, Role of GSTM1, GSTP1, and GSTT1 Gene Polymorphism in Ifosfamide Metabolism Affecting Neurotoxicity and Nephrotoxicity in Children, Journal of Pediatric Hematology/Oncology, 2005, 27, 11, 582

    CrossRef

  59. 59
    Katarina Aleksa, Naomi Halachmi, Shinya Ito, Gideon Koren, Renal ontogeny of ifosfamide nephrotoxicity, Journal of Laboratory and Clinical Medicine, 2004, 144, 6, 285

    CrossRef

  60. 60
    Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen, Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients, The Cochrane Library,
  61. 61
    Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen, Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients, The Cochrane Library,
  62. 62
    Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen, Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients, The Cochrane Library,
  63. 63
    Renée L Mulder, Marios Paulides, Thorsten Langer, Leontien CM Kremer, Elvira C van Dalen, Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients, The Cochrane Library,
  64. 64
    Sebastiaan L Knijnenburg, Renée L Mulder, Antoinette YN Schouten-Van Meeteren, Arend Bökenkamp, Hester Blufpand, Eline van Dulmen-den Broeder, Margreet A Veening, Leontien CM Kremer, Monique WM Jaspers, Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer, The Cochrane Library,
  65. 65
    Louise Talbot, Helen Spoudeas, Late Effects in Relation to Childhood Cancer,